| Literature DB >> 28633251 |
Kohei Hashimoto1, Kentaroh Miyoshi2, Hisao Mizutani3, Shinji Otani1, Seiichiro Sugimoto1, Masaomi Yamane1, Takahiro Oto1.
Abstract
A 53-year-old man with pulmonary fibrosis associated with Erdheim-Chester disease achieved long-term survival after lung transplantation. Major clinical manifestations included lung and bone injuries, and other vital organs were functionally unaffected by the disease. After a careful observation for the disease progression, he underwent bilateral deceased-donor lung transplantation. He has returned to his normal social life and is doing well without recurrence of Erdheim-Chester disease in the lung allograft or progression in other organs 5 years after transplant. Lung transplantation is a potentially reasonable treatment option for Erdheim-Chester disease involving the lungs if the functions of other vital organs remain stable.Entities:
Mesh:
Year: 2017 PMID: 28633251 DOI: 10.1016/j.athoracsur.2017.02.020
Source DB: PubMed Journal: Ann Thorac Surg ISSN: 0003-4975 Impact factor: 4.330